- Co-Moderators:
- Martin Abeloff, M.D., Sidney Kimmel Comprehensive Cancer Center
at Johns Hopkins
Carolyn Runowicz, M.D., University Hospital of Columbia University College of
Physicians and Surgeons
- 6:00-7:00 p.m.--Annapolis/Chesapeake Room
-
Briefing Session for Moderators, Group Leaders, Writers, and PowerPoint Technicians
- 7:00-9:00 p.m.--Congressional Ballroom
-
Introduction--Andrew von Eschenbach, M.D., Director, National Cancer Institute
Epidemiology Keynote--Robert Hoover, M.D., Sc.D., Division of Cancer Epidemiology and Genetics, National Cancer Institute
Do epidemiologic observations provide a consistent picture regarding biologic mechanisms underlying relationships of reproductive factors to breast cancer risk?
Laboratory Keynote--Jose Russo, M.D., Fox Chase Cancer Center
Breast development: Normal molecular and cellular biologic events, rodents vs. humans
- Pregnancy-related factors: Risk of breast cancer and biologic correlates in human populations
- 7:00-8:00 a.m.
- Continental Breakfast
- 8:00-8:05 a.m.
- Moderator: Susan Love, M.D., Susan Love MD Breast Cancer Research Foundation
- 8:05-8:25 a.m.
- Leslie Bernstein, Ph.D., University of Southern California, Keck School of Medicine
Pregnancy as it relates to breast cancer risk
- 8:25-8:45 a.m.
- Paolo Toniolo, M.D., M.P.H., New York University School of Medicine
Endogenous hormones and proteins associated with pregnancy
- 8:45-9:05 a.m.
- Janet Daling, Ph.D., Fred Hutchinson Cancer Research Center
Breast cancer tissue markers: Impact of pregnancy
- 9:05-9:20 a.m.
- Questions and Answers
- 9:20-9:35 a.m.
- Break
- Pregnancy-related factors: Biologic correlates and breast cancer risk in animal models
- 9:35-9:40 a.m.
- Moderator: Nancy Davidson, M.D., Sidney Kimmel Comprehensive Cancer
Center at Johns Hopkins
- 9:40-10:00 a.m.
- Barbara Vonderhaar, Ph.D., Center for Cancer Research, National Cancer
Institute
- Pregnancy hormones and tumor formation
- 10:00-10:20 a.m.
- Daniel Medina, Ph.D., Baylor College of Medicine
Rodent models for protection from breast cancer by pregnancy
- 10:20-10:35 a.m.
- Questions and Answers
- 10:35-10:50 a.m.
- Break
- Pregnancy-related risk factors: Biologic correlates from new technologies
- 10:50-10:55 a.m.
- Moderator: Larry Norton, M.D., Memorial Sloan-Kettering Cancer Center
- 10:55-11:15 a.m.
- Kay-Uwe Wagner, Ph.D., University of Nebraska Medical Center
Pregnancy and stem cell populations
- 11:15-11:35 a.m.
- Lewis Chodosh, M.D., Ph.D., University of Pennsylvania
Using microarrays to understand parity-induced protection against breast cancer
- 11:35-11:55 a.m.
- Norman Boyd, D.Sc., Ontario Cancer Institute, Princess Margaret Hospital
Changes in biologic surrogate endpoints associated with pregnancy
- 11:55 a.m.-12:10 p.m.
- Questions and Answers
- 12:10-1:10 p.m.
- Lunch
- Discussion of Unpublished Materials
- 1:10-1:15 p.m.
- Co-Moderators: Martin Abeloff, M.D., Sidney Kimmel Comprehensive Cancer
Center at Johns Hopkins
Carolyn Runowicz, M.D., University Hospital of Columbia University College of
Physicians and Surgeons
- 1:15-2:15 p.m.
- Presentation of new scientific data
Polly Newcomb, Ph.D., M.P.H., Fred Hutchinson Cancer Research Center
Mads Melbye, M.D., D.M.Sc., Statens Serum Institut
Dwight Janerich, D.D.S., M.P.H., University of Albany (NY)
Herbert Jacobson, Ph.D., Albany Medical College
Michael Pollak, M.D., McGill University
Charlotte Kuperwasser, Ph.D., Whitehead Institute
Leena Hilakivi-Clarke, Ph.D., Georgetown University
Satyabrata Nandi, Ph.D., University of California at Berkeley
- 2:15-2:45 p.m.
- Break
- Small-group sessions
Group Leaders:
Peggy Neville, Ph.D., University of Colorado Health Sciences Center
Sandra Haslam, Ph.D., Michigan State University
Satyabrata Nandi, Ph.D., University of California at Berkeley
Eugenia Calle, Ph.D., American Cancer Society
Lynn Rosenberg, Sc.D., Boston University School of Public Health
Dimitrios Trichopoulos, M.D., Ph.D., Harvard University School of Public Health
Anders Ekbom, M.D., Ph.D., Karolinska Institute
Dan Medina, Ph.D., Baylor College of Medicine
- 2:45-5:30 p.m.
- Four breakout groups to discuss unresolved questions and ways of answering these questions.
- What do we know and what do we not know about the impact of pregnancy on breast cancer risk?
-
- From human population studies, and which pregnancy-related factors are established breast cancer risk factors, which have been suggested by data but need further pursuit and exploration
- From laboratory investigations, and which potential underlying mechanisms to explain pregnancy-related risk factors are most promising, which need further pursuit and exploration
- Which epidemiologic findings should be pursued in laboratory studies, and which laboratory findings should be pursued in epidemiologic investigations
- Are there specific interdisciplinary studies (incorporation of a laboratory component in an epidemiologic research design) which could substantially advance our knowledge and are feasible at this time
- Are there specific high-priority interdisciplinary studies that are not feasible at this time, and what would it take to establish their feasibility
- What is needed to implement the studies identified to fill the research gaps?
-
- Methodologic issues (both epidemiologic and laboratory) that need to be addressed
- Identification of uniquely informative populations for study
- Identification of important new technologies that should be utilized, refined further before utilization, or require development
- Development of epidemiologic and laboratory infrastructures, including consortia, that would enhance and facilitate interdisciplinary studies
- Co-Chairs:
- Peggy Neville, Ph.D., University of Colorado Health Sciences Center
Dimitrios Trichopoulos, M.D., Ph.D., Harvard School of Public Health
- 7:30-9:00 p.m.
- Session for group leaders to develop a draft overall summary of challenges and opportunities
- 7:00-7:45 a.m.
- Continental Breakfast at Bethesda Marriott Pooks Hill - Maryland Suites
- 7:45 a.m.
- Shuttles from Bethesda Marriott to NIH Campus
- NIH Campus, Building 10, Lipsett Auditorium
- Moderators: Martin Abeloff, M.D., Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Carolyn Runowicz, M.D., University Hospital of Columbia University College of Physicians and Surgeons
Co-Chairs: Peggy Neville, Ph.D., University of Colorado Health Sciences Center
Dimitrios Trichopoulos, M.D., Ph.D., Harvard School of Public Health
- 8:30-10:30 a.m.
- Presentation of draft overall summary with comments by group leaders followed by open discussion
- 10:30-11:15 a.m.
- Break during which meeting and group leaders will meet to alter draft
summary, if appropriate, based on discussion
- 11:15-11:45 a.m.
- Presentation of final summary with opportunity for final comments from
participants
- 11:45 a.m.
- Adjourn
- 12:00 p.m.
- Shuttles from NIH Campus to Bethesda Marriott
Back to Top |